Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular

Graham M West1, Francis S Willard2, Kyle W Sloop3

  • 1Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America; Mass Spectrometry and Proteomics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America.

Plos One
|September 3, 2014
PubMed

Insights

Hydrogen/deuterium exchange (HDX) reveals how peptide ligands interact with the glucagon-like peptide-1 receptor (GLP-1R) extracellular domain. This method validates binding for small molecule ligands, aiding type 2 diabetes mellitus (T2DM) drug development.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Structural Biology

Background:

  • The glucagon-like peptide-1 receptor (GLP-1R) is a key therapeutic target for type 2 diabetes mellitus (T2DM).
  • GLP-1R, a class B G protein-coupled receptor (GPCR), has an N-terminal extracellular ligand-binding domain.
  • Modified peptide agonists can act as antagonists by binding without full receptor activation.

Purpose of the Study:

  • To investigate alterations in hydrogen bonding networks of GLP-1R peptide ligands and its N-terminal extracellular domain (nGLP-1R) upon ligand binding using Hydrogen/deuterium exchange (HDX).
  • To establish HDX as a platform for validating direct binding of small molecule ligands to nGLP-1R.

Main Methods:

  • Hydrogen/deuterium exchange (HDX) mass spectrometry.
  • Analysis of peptide ligand (exendin-4 and exendin-4[9-39]) and nGLP-1R interactions.
  • Assessment of ligand stability in the presence of nonionic detergents.

Main Results:

  • HDX detected differential stabilization of hydrogen bonding networks for agonist exendin-4 versus antagonist exendin-4[9-39].
  • Ligand binding stabilized hydrogen bonding networks in the N-terminal helix of both exendin-4 and exendin-4[9-39].
  • HDX confirmed ligand-induced stabilization within the nGLP-1R structure and validated direct binding of small molecule ligands.

Conclusions:

  • HDX is effective in characterizing ligand-receptor interactions at the molecular level for GLP-1R.
  • The study validates HDX as a method for confirming direct binding of small molecule ligands to the GLP-1R extracellular domain.
  • Findings contribute to understanding GLP-1R pharmacology and developing novel T2DM therapeutics.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.8K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
4.7K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.4K